FGF Signaling in the Osteoprogenitor Lineage Non-autonomously Regulates Postnatal Chondrocyte Proliferation and Skeletal Growth
Overview
Affiliations
Fibroblast growth factor (FGF) signaling is important for skeletal development; however, cell-specific functions, redundancy and feedback mechanisms regulating bone growth are poorly understood. FGF receptors 1 and 2 (Fgfr1 and Fgfr2) are both expressed in the osteoprogenitor lineage. Double conditional knockout mice, in which both receptors were inactivated using an osteoprogenitor-specific Cre driver, appeared normal at birth; however, these mice showed severe postnatal growth defects that include an ∼50% reduction in body weight and bone mass, and impaired longitudinal bone growth. Histological analysis showed reduced cortical and trabecular bone, suggesting cell-autonomous functions of FGF signaling during postnatal bone formation. Surprisingly, the double conditional knockout mice also showed growth plate defects and an arrest in chondrocyte proliferation. We provide genetic evidence of a non-cell-autonomous feedback pathway regulating Fgf9, Fgf18 and Pthlh expression, which led to increased expression and signaling of Fgfr3 in growth plate chondrocytes and suppression of chondrocyte proliferation. These observations show that FGF signaling in the osteoprogenitor lineage is obligately coupled to chondrocyte proliferation and the regulation of longitudinal bone growth.
Drug-Loaded Bioscaffolds for Osteochondral Regeneration.
Tong Y, Yuan J, Li Z, Deng C, Cheng Y Pharmaceutics. 2024; 16(8).
PMID: 39204440 PMC: 11360256. DOI: 10.3390/pharmaceutics16081095.
Review of published 467 achondroplasia patients: clinical and mutational spectrum.
Zhang X, Jiang S, Zhang R, Guo S, Sheng Q, Wang K Orphanet J Rare Dis. 2024; 19(1):29.
PMID: 38281003 PMC: 10822181. DOI: 10.1186/s13023-024-03031-1.
Dantsev I, Parfenenko M, Radzhabova G, Nikolaeva E BMC Med Genomics. 2023; 16(1):329.
PMID: 38098042 PMC: 10722747. DOI: 10.1186/s12920-023-01750-1.
Wernle K, Sonnenfelt M, Leek C, Ganji E, Sullivan A, Offutt C Dev Dyn. 2023; 252(9):1180-1188.
PMID: 37212424 PMC: 10524747. DOI: 10.1002/dvdy.600.
Targeted deletion of Fgf9 in tendon disrupts mineralization of the developing enthesis.
Ganji E, Leek C, Duncan W, Patra D, Ornitz D, Killian M FASEB J. 2023; 37(3):e22777.
PMID: 36734881 PMC: 10108073. DOI: 10.1096/fj.202201614R.